Mark Fletcher, EVP & General Counsel at GENEREX BIOTECHNOLOGY CORP (GNBT), bought 12,359 shares at $0.33 ($4K) on 2009-01-12, disclosed to the SEC on 2009-01-12.
Open-market purchase of $4k GNBT by EVP & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.32 | 10,159 | $3K | 81.7% |
| 2 | $0.33 | 2,200 | $726 | 18.3% |
| Total | $0.32 avg | 12,359 | $4K | 100% |
| Filing → |
| GNBT | BUY | 2009-11-16 | $5K | — | Filing → |
| GNBT | BUY | 2008-11-03 | $9K | — | Filing → |
| GNBT | SELL | 2008-04-21 | $263K | — | Filing → |